AwardedAwarded 6 July 2026

NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

NHS England · NHS and health

In brief

NHS England awarded medical supplies work to Roche Products Ltd, Accord-UK Ltd and Biosimilar Collaborations Ireland Limited and 22 others on 6 July 2026.

It is a framework worth up to £592,363,416 excluding VAT: the most the buyer expects to spend across all suppliers, not one contract.

It is split into 2 lots, so a supplier can bid for part of the work.

The buyer says it is suitable for small and medium-sized businesses.

Built from the notice's own fields. Always check the official notice before you bid.

What the notice says

NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Lots

Lot	Trade	Value
Lot 1 - Tranche B for London & South of England 1 September 2026 to 31 August 2028 What this lot covers NHS Branded Medicines - Tranche B for London & South of England	Medical equipment and supplies	£541,494,660
Lot 2 - Ustekinumab for North of England and Midlands & East 1 September 2026 to 31 August 2027 What this lot covers NHS Branded Medicines - Ustekinumab for North of England and Midlands & East	Medical equipment and supplies	£50,868,757

Who won

Winner	Lot	Value	Dates
Roche Products Ltd Accord-UK Ltd Biosimilar Collaborations Ireland Limited Celltrion Healthcare United Kingdom Limited Teva UK Limited (SME) Zentiva Pharma UK Ltd (SME) Gedeon Richter UK Ltd (SME) Fresenius Kabi Limited Amgen Ltd Thornton & Ross Limited DR Reddy's Laboratories (UK) Limited AVENTIS PHARMA LIMITED t-a Sanofi Biogen Idec Limited Glaxosmithkline UK Limited Milpharm Limited Orifarm UK Ltd (SME) Pfizer Limited Sandoz Limited (SME) Abbvie Ltd Alfasigma UK Limited (SME) Janssen-Cilag Limited Organon Pharma (UK) Limited Samsung Bioepis UK Limited Swedish Orphan Biovitrum Ltd (SME) Ucb Pharma Limited 26 bids received	Lot 1 - Tranche B for London & South of England	£813,863,584	1 September 2026 to 31 August 2028
Biosimilar Collaborations Ireland Limited Celltrion Healthcare United Kingdom Limited Gedeon Richter UK Ltd (SME) Fresenius Kabi Limited Amgen Ltd Thornton & Ross Limited Sandoz Limited (SME) Janssen-Cilag Limited 8 bids received	Lot 2 - Ustekinumab for North of England and Midlands & East	£18,903,212	1 September 2026 to 31 August 2027
Roche Products Ltd Accord-UK Ltd Biosimilar Collaborations Ireland Limited Celltrion Healthcare United Kingdom Limited Teva UK Limited (SME) Zentiva Pharma UK Ltd (SME) Gedeon Richter UK Ltd (SME) Fresenius Kabi Limited Amgen Ltd Thornton & Ross Limited DR Reddy's Laboratories (UK) Limited AVENTIS PHARMA LIMITED t-a Sanofi Biogen Idec Limited Glaxosmithkline UK Limited Milpharm Limited Orifarm UK Ltd (SME) Pfizer Limited Sandoz Limited (SME) Abbvie Ltd Alfasigma UK Limited (SME) Janssen-Cilag Limited Organon Pharma (UK) Limited Samsung Bioepis UK Limited Swedish Orphan Biovitrum Ltd (SME) Ucb Pharma Limited 26 bids received	Lot 1 - Tranche B for London & South of England	£813,863,584	Awarded 1 June 2026
Celltrion Healthcare United Kingdom Limited Gedeon Richter UK Ltd (SME) Fresenius Kabi Limited Amgen Ltd Thornton & Ross Limited Biogen Idec Limited Sandoz Limited (SME) Janssen-Cilag Limited 8 bids received	Lot 2 - Ustekinumab for North of England and Midlands & East	£18,903,212	Awarded 1 June 2026

Values as the award notice gives them, excluding VAT where stated.

Timeline

14 January 2026Preliminary market engagement notice · UK2, notice 002947-2026
18 February 2026Preliminary market engagement notice · UK2, notice 014706-2026
23 February 2026Tender notice · UK4, notice 016135-2026
9 June 2026Contract award notice · UK6, notice 054102-2026
10 July 2026Contract details notice · UK7, notice 065041-2026

Last time this was bought

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Won by: Bayer Public Limited Company, Roche Products Ltd, Accord-UK Ltd, Teva UK Limited and 21 more
Awarded: 6 July 2026
Value: Not stated, or split across lots
Contract ends: 31 August 2028

Matched on NHS England, the type of work and the title. Check the notice to be sure.

About the buyer

NHS EnglandLast 12 months

Procurements

1193

Awards

478

Suppliers it has used most for medical supplies

Accord-UK Ltd11 contracts
Teva UK Limited10 contracts
Zentiva Pharma UK Ltd10 contracts
Milpharm Limited8 contracts
Thornton & Ross Limited8 contracts

All tenders and awards from NHS England

Similar open tenders

All open medical supplies tenders

Closes 19Oct
NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping
NHS EnglandNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South WestMedical equipment and supplies
Open19 days left2 lotsSuitable for SMEsFramework
£432mframework ceiling

From notice 002947-2026 on Find a Tender, first published 14 January 2026, last updated 10 July 2026. We last checked for changes on 28 September 2026.